- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07542431
Impact van hondenadoptie en -training bij veteranen met posttraumatische stresssymptomen en/of andere psychische aandoeningen (VCRM)
Beoordeling van biopsychosociale indicatoren die verband houden met de behandelingsrespons op hondeninterventie bij veteranen met posttraumatische stresssymptomen en/of andere psychische aandoeningen
The goal of this single-arm study is to learn if a dog adoption and training program can treat, prevent in [describe participant population/primary condition; could include any of the following: sex/gender, age groups, healthy volunteers]. The main questions it aims to answer are:
- Does the dog adoption and training program decrease posttraumatic stress symptoms in veterans with self-reported posttraumatic stress symptoms?
- Does the dog adoption and training program decrease stress and improve psychosocial health in veterans with self-reported posttraumatic stress symptoms?
- Does the dog adoption and training program decrease inflammation, increase oxytocin, and change the structure and resting-state function of specific brain regions in veterans with self-reported posttraumatic stress symptoms?
Participants will:
- Attend eight one-hour professional dog training sessions within a 10-week period.
- Visit the clinical research unit four times during the study for data collection.
Studie Overzicht
Toestand
Interventie / Behandeling
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
- Naam: Beth A Pratt, PhD
- Telefoonnummer: 561-297-4227
- E-mail: bpratt4@health.fau.edu
Studie Locaties
-
-
Florida
-
Boca Raton, Florida, Verenigde Staten, 33431
- Werving
- Florida Atlantic University
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Military veteran with self-reported posttraumatic stress symptoms and/or other mental health conditions
- Over 18 years of age
- Applied and approved to adopt a shelter dog for training through the Humane Society of Broward County in Fort Lauderdale, Florida
- English speaker (written and spoken)
- Home internet access via tablet, computer or smartphone.
Exclusion Criteria:
- Fear of dogs
- Allergies to pet dander
- Uncorrected hearing or visual impairment.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Ander
- Toewijzing: NVT
- Interventioneel model: Opdracht voor een enkele groep
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Study Intervention
Within-subjects design |
Eight, one-hour professional dog training sessions over 8-10 weeks |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change in self-reported posttraumatic stress disorder (PTSD) symptoms from baseline to 4 weeks post-intervention
Tijdsspanne: From enrollment to 4 weeks post-intervention
|
Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5) is a 20-item self-report measure of PTSD symptoms with scores ranging from 0 to 80. |
From enrollment to 4 weeks post-intervention
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change in depression symptom severity from baseline to 4 weeks post-intervention
Tijdsspanne: From enrollment to 4 weeks post-intervention
|
Patient Health Questionnaire-9 (PHQ-9) is a 9-item self-report measure of depressive symptoms with scores ranging from 0 to 27. |
From enrollment to 4 weeks post-intervention
|
|
Change in anxiety symptom severity from baseline to 4 weeks post-intervention
Tijdsspanne: From enrollment to 4 weeks post-intervention
|
Generalized Anxiety Disorder-7 (GAD-7) is a is a 7-item self-report measure of anxiety symptoms with scores ranging from 0 to 21. |
From enrollment to 4 weeks post-intervention
|
|
Change in perceived stress severity from baseline to 4 weeks post-intervention
Tijdsspanne: From enrollment to 4 weeks post-intervention
|
Perceived Stress Scale-10 (PSS-10) is a 10-item self-report measure of perceived stress symptoms with scores ranging from 0 to 40. |
From enrollment to 4 weeks post-intervention
|
|
Change in sleep disturbance from baseline to 4 weeks post-intervention
Tijdsspanne: From enrollment to 4 weeks post-intervention
|
Patient-Reported Outcomes Measurement Information System Sleep 8b (PROMIS Sleep 8b) is an 8-item self-report measure of sleep quality over the past 7 days with raw scores ranging from 8 to 40 and standardized T scores ranging from 28.9 to 76.5. |
From enrollment to 4 weeks post-intervention
|
|
Change in loneliness from baseline to 4 weeks post-intervention
Tijdsspanne: From enrollment to 4 weeks post-intervention
|
Revised UCLA Loneliness Scale is a 20-item self-report measure of loneliness with scores ranging from 20 to 80. |
From enrollment to 4 weeks post-intervention
|
|
Change in alcohol use from baseline to 4 weeks post-intervention
Tijdsspanne: From enrollment to 4 weeks post-intervention
|
Alcohol Use Disorder Identification Test (AUDIT) is a 10-item self-report measure of alcohol use with scores ranging from 0 to 40. |
From enrollment to 4 weeks post-intervention
|
|
Change in cannabis use from baseline to 4 weeks post-intervention
Tijdsspanne: From enrollment to 4 weeks post-intervention
|
Cannabis Use Disorder Identification Test (CUDIT) is an 8-item self-report measure of cannabis use with scores ranging from 0 to 32. |
From enrollment to 4 weeks post-intervention
|
|
Change in salivary oxytocin levels from baseline to 4 weeks post-intervention
Tijdsspanne: From enrollment to 4 weeks post-intervention
|
Oxytocin is a neurotransmitter that plays a role in determining social behavior. Salivary oxytocin levels range from 6.4-1000 pg/mL. |
From enrollment to 4 weeks post-intervention
|
|
Change in Interleukin-1 beta (IL-1β) from baseline to 4 weeks post-intervention
Tijdsspanne: From enrollment to 4 weeks post-intervention
|
IL-1β is a pro-inflammatory cytokine found to be higher in individuals with PTSD compared to healthy controls. IL-1β is measured via capillary blood obtained via fingerstick. |
From enrollment to 4 weeks post-intervention
|
|
Change in Interleukin-6 (IL-6) from baseline to 4 weeks post-intervention
Tijdsspanne: From enrollment to 4 weeks post-intervention
|
IL-6 is a pro-inflammatory cytokine found to be higher in individuals with PTSD compared to healthy controls. IL-6 is measured via capillary blood obtained via fingerstick. |
From enrollment to 4 weeks post-intervention
|
|
Change in tumor necrosis factor-alpha (TNF-alpha) from baseline to 4 weeks post-intervention
Tijdsspanne: From enrollment to 4 weeks post-intervention
|
TNF-alpha is a pro-inflammatory cytokine found to be higher in individuals with PTSD compared to healthy controls. TNF-alpha is measured via capillary blood obtained via fingerstick. |
From enrollment to 4 weeks post-intervention
|
Andere uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change in alcohol demand for participants who answer "yes" to alcohol consumption in the AUDIT measure from baseline to 4 weeks post-intervention
Tijdsspanne: From enrollment to 4 weeks post-intervention
|
Alcohol Purchase Task is a tool to measure alcohol demand by asking individuals how many drinks they would consume at prices ranging from free to high, using behavioral economic indices for scoring. |
From enrollment to 4 weeks post-intervention
|
|
Change in cannabis demand for participants who answer "yes" to cannabis use from baseline to 4 weeks post-intervention
Tijdsspanne: From enrollment to 4 weeks post-intervention
|
Cannabis Purchase Task is a tool to measure cannabis demand by assessing how much an individual purchases at increasing prices. |
From enrollment to 4 weeks post-intervention
|
|
Change in Magnetic Resonance Imaging (MRI) biomarkers from baseline to 4 weeks post-intervention
Tijdsspanne: Pre-intervention and 4 weeks post-intervention
|
Optional participation in an MRI to detect changes in the structure and resting-state function of specific brain regions (anterior cingulate, amygdala, hippocampus, and insula) |
Pre-intervention and 4 weeks post-intervention
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Hoofdonderzoeker: Beth A Pratt, PhD, Florida Atlantic University
- Hoofdonderzoeker: Cheryl A Krause-Parello, PhD, Florida Atlantic University
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Andere studie-ID-nummers
- IRB2310227
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .